Clinical Trials Logo

Fasting clinical trials

View clinical trials related to Fasting.

Filter by:

NCT ID: NCT01602055 Completed - Fasting Clinical Trials

A Bioequivalence Study of Two Azithromycin Tablet Formulations in Indonesian Healthy Subjects

Start date: October 2010
Phase: Phase 1
Study type: Interventional

The aim of this study is to assess the bioequivalence of 500 mg Azithromycin FC tablets (Azivol) produced by PT. Novell Pharmaceutical Laboratories, compared to the reference product Zithromax 500 mg FC tablet produced by Pfizer Australia Pty, Ltd

NCT ID: NCT01506713 Completed - Fasting Clinical Trials

Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions

Start date: September 2006
Phase: Phase 1
Study type: Interventional

The objective of this study was to compare the rate and extent of absorption of Dr. Reddy's Laboratories Ltd, clopidogrel and Bristol-Myers Squibb Company, USA Plavix®, clopidogrel 75 mg tablet under fasting condition.

NCT ID: NCT01506076 Completed - Fasting Clinical Trials

Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting Conditions

Start date: December 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the Bioequivalence of Levocetirizine DiHCl Tablets 5mg with XYZAL tablets 5 mg and to monitor clinical status, adverse events and laboratory investigations and assess relative safety and tolerance, under fasting conditions.

NCT ID: NCT01506011 Completed - Fasting Clinical Trials

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions

Start date: March 2007
Phase: Phase 1
Study type: Interventional

The purpose of this study single dose bioequivalence of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg capsules with Lotrel® capsules in healthy human subjects and monitor clinical status, adverse events and laboratory investigations and assess relative safety and tolerance under fasting conditions

NCT ID: NCT01503437 Completed - Fasting Clinical Trials

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition

Start date: November 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the single oral dose bioequivalence of olanzapine 5 mg OD tablets with Zyprexa Zydis 5 mg tablets under fasting conditions and to monitor adverse events and ensure safety of subjects.

NCT ID: NCT01503398 Completed - Fasting Clinical Trials

Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions

Start date: August 2011
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the bioequivalence and characterize the profile of the olanzapine tablets, 5 mg with zyprexa tablets, 5 mg in healthy, adult, human subjects under fasting conditions and to monitor the adverse events and ensure the safety of the subjects.

NCT ID: NCT01372345 Completed - Fasting Clinical Trials

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions

Start date: February 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the relative bioavailability of ciprofloxacin 1000 mg ER tablets of Dr.Reddy's with that of CIPRO® XR 1000 mg of Bayer Pharmaceuticals Corporation in healthy, adult, non-smoking subjects under fasting conditions.

NCT ID: NCT01372280 Completed - Fasting Clinical Trials

Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition

Start date: October 2004
Phase: Phase 1
Study type: Interventional

Galantamine Hydrobromide Tablets, Bioequivalence study of Dr. Reddy's under Fasting condition.

NCT ID: NCT01314339 Completed - Fasting Clinical Trials

Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.

Start date: December 2005
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the rate and extent of absorption of Dr. Reddy's Desloratadine 5 mg tablet to that of Clarinex® 5 mg tablet in healthy subjects under fasting conditions.

NCT ID: NCT01286688 Completed - Fasting Clinical Trials

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions

Start date: January 2002
Phase: Phase 1
Study type: Interventional

The purpose of this study is to compare the rate and extent of absorption of terbinafine hydrochloride 250 mg tablets versus Lamisil® 250 mg tablets administered as 1 x 250 mg tablet under fasting conditions.